CV Dr. Anja Feldmann
Positions
| since 2019 | Head of Department Radioimmunology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden |
| 2013-2019 | Postdoctoral senior scientist, Institute of Radiopharmaceutical Cancer Research, HZDR, Dresden |
| 2010-2012 |
Postdoctoral research fellow, Department Tumor Immunology, Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden |
| 2006-2010 | PhD student, Institute of Immunology, Medical Faculty Carl Gustav Carus, TU Dresden |
Education
| 2006-2010 | PhD in Tumor Immunology, School of Science, TU Dresden |
| 2000-2005 | Study of Biology, School of Science, TU Dresden |
Honors
| 2010 | PhD with highest distinction (Dr. rer. nat., summa cum laude) |
| 2007-2010 |
Scholarship for post-graduate students from the Free State of Saxony, Germany |
| 2005 | Diploma of Biology with highest distinction |
Memberships
| since 2023 | Member of the Helmholtz Biomedical Engineering Initiative |
| since 2022 |
PI at the German Cancer Consortium (DKTK), Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany; PI at the National Center for Tumor Diseases Dresden (NCT/UCC) |
| since 2021 | Executive board member of the Helmholtz Immunology & Inflammation (I&I) Initiative |
| since 2021 |
PI in the BMFTR Cluster4Future SaxoCell |
| 2021-2026 |
WP consultant, International Lab “MHELTHERA” |
Funding
| 2026-2028 | Helmholtz Biomedical Engineering Initiative “RoboT3” |
| 2024-2027 | SMWK TG 70, SAB “KI-CARs” |
| 2024-2027 | EP PerMed “COMBAT-PDAC” |
| 2023-2027 |
Horizon EIC Pathfinder Challenges Network “B-specific” |
| 2022-2026 | Horizon Europe MSCA Doctoral Network “OncoProTools” |
| 2022-2026 | Horizon Europe MSCA Doctoral Network “TOLERATE” |
| 2021-2027 |
BMFTR Cluster4Future SaxoCell TheraSTAR and UniK-T |
| 2021-2026 | Helmholtz Initiative and Networking Fund, International Lab “MHELTHERA” |